EP2430443
BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
13.5.2010EP published:
27.6.2018EP application number:
10720095.8
EPO information:
European Patent Register
Max expiry date:
12.5.2030
Title:
BIOMARKERS FOR DETERMINING SENSITIVITY OF BREAST CANCER CELLS TO HER2-TARGETED THERAPY
Timeline
Today
13.5.2010EP application
27.6.2018EP Publication
Owner
Name:
Pierian Holdings, Inc.Address:
405 Duke Drive, Suite 240, 37067, Franklin, TN, US
Inventor
Name:
KIM, PhillipAddress:
IrvineCalifornia, US
Name:
LIU, XinjunAddress:
San DiegoCalifornia, US
Name:
KIRKLAND, RichardAddress:
San DiegoCalifornia, US
Name:
LEE, TaniAddress:
San DiegoCalifornia, US
Name:
YBARRONDO, BelenAddress:
San DiegoCalifornia, US
Name:
SINGH, SharatAddress:
Rancho Santa FeCalifornia, US
Priority
Number:
178458 PDate:
14.5.2009Country:
US
Number:
180787 PDate:
22.5.2009Country:
US
Number:
187246 PDate:
15.6.2009Country:
US
Number:
228522 PDate:
24.7.2009Country:
US
Number:
235646 PDate:
20.8.2009Country:
US
Number:
241804 PDate:
11.9.2009Country:
US
Number:
262856 PDate:
19.11.2009Country:
US
Number:
265227 PDate:
30.11.2009Country:
US
Classification
Categories:
G01N 33/50, G01N 33/532, G01N 33/533, G01N 33/535, G01N 33/543, G01N 33/574